+7 (701) 759 90 19
USD 428.68 EUR 507.21
RUB 5.57 CNY 64.2
News

Japanese bio-venture starts development of COVID-19 peptide vaccine

1 October 2020 11:16
Share in:
Japanese bio-venture starts development of COVID-19 peptide vaccine

TOKYO. KAZINFORM - A biotechnology venture in Japan said Thursday it started research and development of a peptide vaccine against the coronavirus and has completed a patent application filing, Kyodo reports.

Related news
Kazakhstan adds over 150 new COVID-19 cases After 7 months, Philippines to welcome back visa-holding foreigners Over one-third of Italians under curfew amid coronavirus spike

The vaccine could be effective in controlling the virus infection and suppressing the severe progression of COVID-19, the respiratory disease caused by the novel coronavirus, OncoTherapy Science Inc. said in a statement.

Founded in 2001, OncoTherapy Science based in Kawasaki, Kanagawa Prefecture, has been working to develop cancer peptide vaccines and to provide a service for antigen-specific immune response analysis.



Share in:
+7
Send
Employees online
Editor
Nurmaganbetova Zhanna
Nurmaganbetova Zhanna
954-048
Editor
Kudrenok Tatyana
Kudrenok Tatyana
954-048
Editor
Seilkhanov Adlet
Seilkhanov Adlet
954-048

Archive